Beaking News
Drug-resistant tuberculosis reversed in the lab
Green tea plant compound may help fight TB: Study
Industry - Academia Partnership can bring about new TB treatment methods : Prof. Mala Menon
Common antibiotic found useful in accelerating recovery in tuberculosis patients
Due to Disruptions Caused by COVID-19, India’s TB Notifications Fell by 25%
Let’s Talk About Tuberculosis
Main navigation
Home
About
Magazine
Editorial
TBInfo Articles
News Articles
Pharmaceuticals
Clinical Trials
Past Events
Upcoming Events
Research Articles
Doctor & Patient Corner
YouTube Channel
Community Engagement
Student corner
Blog
Nutrition
Video
List of Organisations
ASIA
AFRICA
AUSTRALIA
INDIA
EUROPE
USA
Contact
Menu second
Gallery
Search
Breadcrumb
Home
/
Research Articles
Research Articles
Article Published Year
- Any -
1940-1949
1950-1959
1960-1969
1970-1979
1980-1989
1990-1999
2000-2009
2010-2019
2020-2029
Research Articles on Tuberculosis from 1940 onwards
Anti-mycobacterial activity of garlic (Allium sativum) against multi-drug resistant and non-multi-drug resistant mycobacterium tuberculosis.
Pak J Pharm Sci. 2011 Jan;24(1):81-5.
Cytoplasmic RNA Sensor Pathways and Nitazoxanide Broadly Inhibit Intracellular Mycobacterium tuberculosis Growth.
iScience. 2019 Nov 6;22:299-313.
Efflux Attenuates the Antibacterial Activity of Q203 in Mycobacterium tuberculosis.
Antimicrob Agents Chemother. 2017 Jun 27;61(7). pii: e02637-16.
Metformin and its anti-inflammatory and anti-oxidative effects; new concepts
Metformin promotes lifespan through mitohormesis via the peroxiredoxin PRDX-2.
Proc Natl Acad Sci U S A. 2014 Jun 17;111(24):E2501-9.
Metformin activates type I interferon signaling against HCV via activation of adenosine monophosphate-activated protein kinase
Oncotarget. 2017 Nov 3; 8(54): 91928–91937.
Metformin induces apoptosis of human hepatocellular carcinoma HepG2 cells by activating an AMPK/p53/miR-23a/FOXA1 pathway
Onco Targets Ther. 2016; 9: 2845–2853.
Plants in our combating strategies against Mycobacterium tuberculosis: progress made and obstacles met
Pharm Biol. 2017; 55(1): 1536–1544.
The anti-mycobacterial activity of the cytochrome bcc inhibitor Q203 can be enhanced by small-molecule inhibition of cytochrome bd.
Sci Rep. 2018 Feb 8;8(1):2625.
Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis.
Nat Med. 2013 Sep;19(9):1157-60.
Pagination
First page
« First
Previous page
‹‹
…
Page
30
Page
31
Page
32
Page
33
Current page
34
Page
35
Page
36
Page
37
Page
38
…
Next page
››
Last page
Last »
Recent Posts
01
Green tea plant compound may help fight TB: Study
02
Drug-resistant tuberculosis reversed in the lab
03
Common antibiotic found useful in accelerating recovery in tuberculosis patients
04
Industry - Academia Partnership can bring about new TB treatment methods : Prof. Mala Menon
05
Due to Disruptions Caused by COVID-19, India’s TB Notifications Fell by 25%
06
Amitabh Bachchan on TB